🇺🇸 FDA
Patent

US 10939673

Method of using mouse having a humanized cluster of differentiation 47 gene

granted A61PA61P35/00

Quick answer

US patent 10939673 (Method of using mouse having a humanized cluster of differentiation 47 gene) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00